Thought Leadership
Digital Therapeutics in Oncology (PART ONE):Advancing Outcomes Design
The digital health market is flooded with direct-to-consumer health and wellness applications. Digital health is a broad category that includes digital therapeutics (DTx)…
With DTx in oncology showing great promise, we have outlined the current state of development, emerging applications, future trends, and strategies. In Part 1: Advancing Outcomes Design, we take a look at these new treatments from the clinical perspective. Our experts conducted a trend analysis of 12 marketed DTx solutions in oncology to understand its application àrees or utilitzi casis. We also identified the four factors driving DTx in oncology: the complexity of the patient journey, the shift to remote treatment, personalized care, and holistic care.
In Part 2: Innovation Models, we take a deep dive into the evaluation criteria for Digital Therapeutics in Oncology. Our experts explori business questions that ca stimulate innovation discovery and implementation. New revenue streams llauri on the horizon, primed to transform the sector for years to menja.
